[New antineoplastic agents, their value and use].
D000585:Aminacrine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008777:Methyltestosterone / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011929:Razoxane / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D013713:Teniposide / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014748:Vinca Alkaloids; D013629:Tamoxifen; D001224:Aspartic Acid; D011929:Razoxane; D005047:Etoposide; D000585:Aminacrine; C013195:sparfosic acid; D007372:Interferons; D013713:Teniposide; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone; C013389:4'-(9-acridinylamino)methanesulfonanilide; D010746:Phosphonoacetic Acid; D002945:Cisplatin; D007069:Ifosfamide; D008777:Methyltestosterone
Nowe preparaty przeciwnowotworowe, ich znaczenie i zastosowanie.